Aptar Pharma Advances FDA-Supported Research on Next-Generation Propellants for Metered-Dose Inhalers Aptar Pharma, a global company specializing in drug delivery systems, dosing technologies, protection solutions, and pharmaceutical services, has announced continued progress in its multi-year research collaboration with the U.S.…
Northwell’s Feinstein Institutes Researcher Alex C. Spyropoulos Receives Prestigious Fulbright U.S. Scholar Recognition Alex C. Spyropoulos, an internationally recognized authority in thrombosis and blood clotting disorders, has been awarded a prestigious Fulbright U.S. Scholar distinction for the 2026–2027 academic year.…
SCIEX Enhances Workflow Efficiency Through Software Innovations Backed by Six Strategic Industry Collaborations SCIEX, a subsidiary of Danaher Corporation and a recognized leader in analytical technologies, is advancing its vision of a fully integrated digital ecosystem for modern laboratories through…
Spruce Biosciences Bolsters Commercial Leadership with Appointment of Brian Walls as VP, Market Access, and Darren Johnson as VP, Commercial Operations Spruce Biosciences, a late-stage biopharmaceutical company focused on developing and commercializing therapies for neurological disorders with significant unmet medical…
OpRegen® 3-Year Data in Geographic Atrophy Patients Showcased at Foundation Fighting Blindness Retinal Innovation Summit 2026 Lineage Cell Therapeutics (NYSE American and TASE: LCTX), a clinical-stage biotechnology company focused on developing off-the-shelf allogeneic cell therapies for serious medical conditions, has…
Insulet Launches EVOLVE Pivotal Trial to Accelerate Development of a Fully Closed-Loop Insulin Delivery System for Type 2 Diabetes Insulet Corporation, a global pioneer in tubeless insulin pump technology through its Omnipod® platform, has taken a significant step forward in…
UCB Expands Immunology Pipeline with Planned Acquisition of Candid Therapeutics and Its Novel T-Cell Engager Platform UCB has taken a significant step forward in its strategic expansion within immunology by entering into a definitive agreement to acquire Candid Therapeutics, a…
Knoa Pharma Launches as Public Health-Focused Company Aiming to Support Patients and Combat the Opioid Crisis Knoa Pharma LLC has officially launched as a newly established independent organization with a mission centered on improving public health, ensuring responsible access to…
CorFlow Therapeutics Reports Phase 1 Completion, Initiates Phase 2 Enrollment in MOCA II Trial, Gains EU Approval for REVITALISE RCT, and Expands Clinical Leadership CorFlow Therapeutics AG has announced a series of important clinical and organizational milestones that mark significant…
Ansa Biotechnologies to Highlight Next-Generation DNA Synthesis Innovation with Industry-Exclusive On-Time Delivery Guarantee at SynBioBeta 2026 Ansa Biotechnologies, a biotechnology firm specializing in next-generation DNA synthesis solutions, has announced its participation and presentation lineup for the upcoming SynBioBeta 2026 conference,…
Vensica Medical Secures FDA IND Clearance to Launch Phase 2 Trial of ViXe, a Needle-Free Xeomin® Delivery System for Overactive Bladder Vensica Medical, an emerging innovator in the field of needle-free therapeutic delivery technologies, has announced a significant regulatory milestone…
Anova’s Global Urology Research Network Expands with Addition of 500th Urology Research Site Anova Enterprises, Inc. has announced a major expansion of its virtual urology research network, marking a significant milestone in the evolution of digitally enabled clinical trials. Powered…